Norris Medicines Ltd

📊 Norris Medicines Board Meeting: Q3 & 9M FY2026 Results on Feb 14

• Board meeting scheduled for February 14, 2026 at registered office in Ankleshwar, Gujarat

• Will consider and approve Un-audited Financial Results for quarter and nine months ended December 31, 2025

• Limited Review Report to be reviewed alongside financial results

• Trading window for company securities closed since January 1, 2026

• Trading window will reopen 48 hours after financial results are declared on stock exchange